论文信息 - Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial - 字舞流文

Impact of Cytogenetics on Outcomes of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Continuous Lenalidomide Plus Low-Dose Dexamethasone in the First (MM-020) Trial

M. Dimopoulos | A. Belch | D. Reece | P. Moreau | H. Avet-Loiseau | R. Schots | H. Ludwig | T. Facon | M. Attal | R. LeBlanc | L. Qiu | M. Cavo | L. Benboubker | C. Hulin | S. Rajkumar | J. Catalano | N. Bahlis | Guang Chen | A. Ervin‐Haynes | A. Pinto | J. Marek | W. Yiu